Trials / Terminated
TerminatedNCT03937856
Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases
Smartphone App Mindfulness-Based Intervention for Patients With Rheumatic Diseases
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will assess the effect of a mindfulness meditation program administered via a smartphone application on health-related quality of life for patients with rheumatic disease.
Detailed description
After obtaining written consent, participants will be asked to download and use the Calm meditation smartphone application everyday for a 30-day period. Participant demographics and clinical information will be collected at baseline. Participants will additionally be asked to complete questionnaires concerning health-related quality of life (HRQoL) as well as mental health, stress, and self-efficacy at baseline and at the end of the 30 day study period. A brief check-in via telephone will be conducted on day 15. Participants using the calm app will be compared to participants receiving usual care who will be asked to complete identical sets of questionnaires. The participant may choose whether they join the Calm application vs usual care (questionnaires only) group on a voluntary basis; there is no pre-assignment. The Calm application is a publicly available program that is available to any patient independent of this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Calm- Mindfulness Meditation smartphone application | Participants will be asked to register and download the Calm application on participants' phones or home computer. Daily use for a minimum of 5 minutes will be suggested and will be recorded at study end. |
Timeline
- Start date
- 2019-05-07
- Primary completion
- 2021-04-22
- Completion
- 2021-04-22
- First posted
- 2019-05-06
- Last updated
- 2021-04-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03937856. Inclusion in this directory is not an endorsement.